A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand

• Үндсэн зохиолчид: Kasemsup Vijj (Зохиогч), Hongeng Suradej (Зохиогч), Chaikledkaew Usa (Зохиогч), Leelahavarong Pattara (Зохиогч), Lubell Yoel (Зохиогч), Teerawattananon Yot (Зохиогч)
• Формат: Ном
• Хэвлэсэн: BMC, 2010-07-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Hematopoietic stem cell transplantation (HSCT) is the only curative treatment available to severe thalassemic patients. The treatment, however, is very costly, particularly in the context of low and middle income countries, and no st...